EA201891346A1 - CATHETER FOR MINIMIZING DOSAGE DILUTION DURING DELIVERY OF NITROGEN OXIDE - Google Patents

CATHETER FOR MINIMIZING DOSAGE DILUTION DURING DELIVERY OF NITROGEN OXIDE

Info

Publication number
EA201891346A1
EA201891346A1 EA201891346A EA201891346A EA201891346A1 EA 201891346 A1 EA201891346 A1 EA 201891346A1 EA 201891346 A EA201891346 A EA 201891346A EA 201891346 A EA201891346 A EA 201891346A EA 201891346 A1 EA201891346 A1 EA 201891346A1
Authority
EA
Eurasian Patent Office
Prior art keywords
nitrogen oxide
catheter
during delivery
dilution
dilution during
Prior art date
Application number
EA201891346A
Other languages
Russian (ru)
Inventor
Крейг Флэнаган
Саймон Фрид
Джон Клаус
Томас Колманн
Мартин Д. Меглассон
Манеш Найду
Параг Шах
Original Assignee
МАЛЛИНКРОДТ ХОСПИТАЛ ПРОДАКТС АйПи ЛИМИТЕД
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by МАЛЛИНКРОДТ ХОСПИТАЛ ПРОДАКТС АйПи ЛИМИТЕД filed Critical МАЛЛИНКРОДТ ХОСПИТАЛ ПРОДАКТС АйПи ЛИМИТЕД
Publication of EA201891346A1 publication Critical patent/EA201891346A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0666—Nasal cannulas or tubing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0666—Nasal cannulas or tubing
    • A61M16/0672—Nasal cannula assemblies for oxygen therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases

Abstract

Настоящее изобретение в целом относится, помимо всего прочего, к системам, устройствам, материалам и способам, которые могут улучшить безошибочность и/или точность лечения газом окиси азота путем, например, уменьшения разбавления вдыхаемой окиси азота (NO). Как описано в настоящей заявке, разбавление NO может возникать из-за различных факторов. Для уменьшения разбавления предполагаемой дозы NO в настоящей заявке предложены различные иллюстративные носовые катетеры, пневматические конфигурации, способы изготовления и способы использования, и т.п.The present invention generally relates, among other things, to systems, devices, materials and methods that can improve the accuracy and / or accuracy of a treatment with nitrogen oxide gas by, for example, reducing the dilution of inhaled nitric oxide (NO). As described in this application, the dilution of NO may occur due to various factors. To reduce the dilution of the estimated dose of NO, various illustrative nasal catheters, pneumatic configurations, manufacturing methods and methods of use, and the like are proposed in this application.

EA201891346A 2013-07-19 2013-12-04 CATHETER FOR MINIMIZING DOSAGE DILUTION DURING DELIVERY OF NITROGEN OXIDE EA201891346A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361856367P 2013-07-19 2013-07-19

Publications (1)

Publication Number Publication Date
EA201891346A1 true EA201891346A1 (en) 2019-03-29

Family

ID=65950014

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201891346A EA201891346A1 (en) 2013-07-19 2013-12-04 CATHETER FOR MINIMIZING DOSAGE DILUTION DURING DELIVERY OF NITROGEN OXIDE

Country Status (1)

Country Link
EA (1) EA201891346A1 (en)

Similar Documents

Publication Publication Date Title
EA201590813A1 (en) CATHETER FOR MINIMIZING DOSAGE DILUTION DURING DELIVERY OF NITROGEN OXIDE
TW201613887A (en) Antiproliferative compounds and methods of use thereof
NZ713621A (en) Compounds and methods of treating infections
BR112015022197A8 (en) use of a compound for the manufacture of a medicament or pharmaceutical composition for treating cataplexy
MX2015012397A (en) Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy.
PH12015502013B1 (en) Pharmaceutical composition of s-ketamine hydrochloride
PH12015501957A1 (en) Pharmaceutical composition of s-ketamine hydrochloride
PH12015502593A1 (en) COMPOSITIONS, METHODS and SYSTEMS FOR RESPIRATORY DELIVERY OF THREE OR MORE ACTIVE AGENTS
SG10201810404XA (en) Combination comprising a glucocorticoid and edo-s101
MY193312A (en) Topical formulation for promoting wound healing
MX2016014853A (en) Volatile applications against pathogens.
MX2015011905A (en) Use of levocetirizine and montelukast in the treatment of vasculitis.
PH12015501602A1 (en) Agent for elevating nitric oxide concentration
EA202193343A1 (en) INHALED COMPOSITION CONTAINING CYCLODEXTRIN FOR USE IN THE TREATMENT OF NAZAL INFLAMMATION
MX2016002308A (en) Multiple myeloma treatment.
EA201891008A3 (en) TREATMENT OF SYMPTOMS ASSOCIATED WITH ANDROGEN-DEPRIVATION THERAPY
EA201891346A1 (en) CATHETER FOR MINIMIZING DOSAGE DILUTION DURING DELIVERY OF NITROGEN OXIDE
EA201690445A1 (en) CANCER TREATMENT
EA201890789A1 (en) CONTAINING ZINEOL COMPOSITION FOR THE TREATMENT OF NOSE DISEASES
BR112013010928A2 (en) methods of using inhalation nitric oxide gas for treatment of acute respiratory distress syndrome
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
RU2013106607A (en) METHOD FOR TREATING PLEUROPULMONAL COMPLICATIONS IN PATIENTS WITH ACUTE PANCREATITIS
UA104030U (en) Method for treating patients with acute condition of chronic bronchitis of viral etiology
MX350237B (en) Pharmaceutical composition comprising an hexane-ethyl acetate extract of ageratina pichinchensis and use thereof for treating and curing chronic venous ulcers.
IN2013MU03883A (en)